Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02757755 · ClinicalTrials.gov registry record · Phase 1
Ascending Dose Study of the Safety of AB-SA01 When Topically Applied to Intact Skin of Healthy Adults
A Phase 1 study of Healthy Volunteers, sponsored by Armata Pharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT02757755 is a Phase 1 study of Healthy Volunteers that has completed, run by Armata Pharmaceuticals. The registered enrollment target is 12 participants, below the 482-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02757755, a Phase 1 study of Healthy Volunteers, has completed, sponsored by Armata Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will examine the safety of ascending doses of AB-SA01 when topically applied to intact skin of healthy adults.
Conditions Studied
Interventions
- BIOLOGICAL AB-SA01 (10^8 PFU per phage)
- BIOLOGICAL AB-SA01 (10^9 PFU per phage)
- BIOLOGICAL Placebo (for Cohort 10^8)
- BIOLOGICAL Placebo (for Cohort 10^9)
Study Locations (1)
Maryland
- Clinical Trials Center, WRAIR - Silver Spring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2016-05 |
| Est. Completion | 2016-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02757755
The ClinicalTrials.gov registry entry for NCT02757755 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 482-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (98% lower). The listed sponsor is Armata Pharmaceuticals, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Healthy Volunteers appearing as the primary indexed condition, and to 4 interventions - of which AB-SA01 (10^8 PFU per phage) is the first listed.
NCT02757755 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT02757755 about?
NCT02757755 is a clinical study titled "Ascending Dose Study of the Safety of AB-SA01 When Topically Applied to Intact Skin of Healthy Adults". This study will examine the safety of ascending doses of AB-SA01 when topically applied to intact skin of healthy adults.
What is the current status of trial NCT02757755?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2016-05. Estimated completion is 2016-08.
What conditions does trial NCT02757755 study?
This clinical trial studies the following conditions: Healthy Volunteers.
What interventions are being tested in trial NCT02757755?
The interventions under investigation include: AB-SA01 (10^8 PFU per phage) (BIOLOGICAL), AB-SA01 (10^9 PFU per phage) (BIOLOGICAL), Placebo (for Cohort 10^8) (BIOLOGICAL), Placebo (for Cohort 10^9) (BIOLOGICAL).
Who is sponsoring clinical trial NCT02757755?
This trial is sponsored by Armata Pharmaceuticals, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02757755 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Volunteers
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Research Study to Evaluate the Safety of NNC4004-0002 When Given to Participants With Asymptomatic Hyperuricemia
RECRUITING · Phase 1
-
A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of ABBV-243 in Healthy Adults.
RECRUITING · Phase 1
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of ABBV-277 in Healthy Adult Participants
RECRUITING · Phase 1
-
A Study to Evaluate the Effect of Single Oral Dose of Balinatunfib on Cardiac Repolarization in Healthy Adult Participants.
RECRUITING · Phase 1
-
Classroom Break, Cognition, and Fitness in Elementary School Children
RECRUITING · Phase 1
-
A Study to Assess the Relative Bioavailability of BMS-986435 and Food Effect on the BMS-986435 in Healthy Adult Participants
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.